Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis
- 1 February 1989
- Vol. 63 (3) , 578-582
- https://doi.org/10.1002/1097-0142(19890201)63:3<578::aid-cncr2820630330>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Management of Chemotherapy-Induced Nausea and VomitingMedical Clinics of North America, 1987
- High-dose oral metoclopramideAmerican Journal of Clinical Oncology, 1985
- Optimizing Metoclopramide Control of Cisplatin-Induced EmesisAnnals of Internal Medicine, 1984
- A pilot study of lorazepam-induced amnesia with cis-platinum-containing chemotherapyGynecologic Oncology, 1984
- IMPAIRMENT OF RECALL IMPROVES TOLERANCE OF CYTOTOXIC CHEMOTHERAPYThe Lancet, 1983
- LORAZEPAM AS AN ADJUNCT TO ANTIEMETIC THERAPY WITH HALOPERIDOL IN PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPYAustralian and New Zealand Journal of Medicine, 1983
- Improved Tolerance of Cytotoxic Chemotherapy with LorazepamOncology, 1983
- Intravenous MetoclopramideJAMA, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- How to Use Ridit AnalysisPublished by JSTOR ,1958